Search

Your search keyword '"M., Ford"' showing total 275 results

Search Constraints

Start Over You searched for: Author "M., Ford" Remove constraint Author: "M., Ford" Publication Year Range Last 3 years Remove constraint Publication Year Range: Last 3 years
275 results on '"M., Ford"'

Search Results

2. Spatial transcriptome-guided multi-scale framework connects P. aeruginosa metabolic states to oxidative stress biofilm microenvironment.

4. An answered call for aid? Cannabinoid clinical framework for the opioid epidemic

5. Microfluidic Isolation of Neuronal-Enriched Extracellular Vesicles Shows Distinct and Common Neurological Proteins in Long COVID, HIV Infection and Alzheimer’s Disease

6. Blood Markers Show Neural Consequences of LongCOVID-19

7. Gender bias in autism screening: measurement invariance of different model frameworks of the Autism Spectrum Quotient

8. Antitumour activity of neratinib in patients with HER2-mutant advanced biliary tract cancers

10. Spectroscopic r-process Abundance Retrieval for Kilonovae. II. Lanthanides in the Inferred Abundance Patterns of Multicomponent Ejecta from the GW170817 Kilonova

11. KilonovAE: Exploring Kilonova Spectral Features with Autoencoders

12. Advances in cellular and molecular predatory biology of Bdellovibrio bacteriovorus six decades after discovery

13. How does conservation land tenure affect economic impacts of wildlife: An analysis of subsistence farmers and herders in Bhutan

14. In-hospital stress and patient outcomes: A systematic review and meta-analysis

15. Multi-model order spatially constrained ICA reveals highly replicable group differences and consistent predictive results from resting data: A large N fMRI schizophrenia study

17. Advanced brain age correlates with greater rumination and less mindfulness in schizophrenia

18. Cerebellar stimulation in schizophrenia: A systematic review of the evidence and an overview of the methods

20. Federally Qualified Health Center Penetration Associated With Reduced Community COVID-19 Mortality in Four United States Cities

21. Generalization of Runoff Risk Prediction at Field Scales to a Continental‐Scale Region Using Cluster Analysis and Hybrid Modeling

22. Statistical assessment on determining local presence of rare bat species

23. 270 Development of a Predictive Nomogram for Circumferential Resection Margin in Rectal Cancer Surgery

24. Psychological Dimensions Relevant to Motivation and Pleasure in Schizophrenia

25. From Sound Perception to Automatic Detection of Schizophrenia: An EEG-Based Deep Learning Approach

26. Aperiodic measures of neural excitability are associated with anticorrelated hemodynamic networks at rest: A combined EEG-fMRI study

31. A Case Report of Severe Factor XI Deficiency during Cardiac Surgery: Less Can Be More

32. Multimodel Order Independent Component Analysis: A Data-Driven Method for Evaluating Brain Functional Network Connectivity Within and Between Multiple Spatial Scales

34. National Cancer Institute Combination Therapy Platform Trial with Molecular Analysis for Therapy Choice (ComboMATCH)

37. The Low-redshift Lyman Continuum Survey. II. New Insights into LyC Diagnostics

38. The Low-redshift Lyman Continuum Survey. I. New, Diverse Local Lyman Continuum Emitters

40. Long-term bowel dysfunction and decision regret in diverticulitis: A mixed methods study

41. Clinical Trial Development in TP53-Mutated Locally Advanced and Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma

42. Enhancing Repair of Oxidative DNA Damage with Small-Molecule Activators of MTH1

43. The Gastric Cancer Registry: A Genomic Translational Resource for Multidisciplinary Research in Gastric Cancer

44. Single-cell analyses define a continuum of cell state and composition changes in the malignant transformation of polyps to colorectal cancer

45. Somatic tumor testing implications for Lynch syndrome germline genetic testing

47. The Scanner as the Stimulus: Deficient Gamma-BOLD Coupling in Schizophrenia at Rest

48. supplementary table TS1 from National Cancer Institute Combination Therapy Platform Trial with Molecular Analysis for Therapy Choice (ComboMATCH)

49. Data from National Cancer Institute Combination Therapy Platform Trial with Molecular Analysis for Therapy Choice (ComboMATCH)

50. Large-scale analysis of structural brain asymmetries in schizophrenia via the ENIGMA consortium

Catalog

Books, media, physical & digital resources